Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
SSBI vs HAFC vs JPM vs HOPE vs BCAL
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
Banks - Regional
Banks - Regional
SSBI vs HAFC vs JPM vs HOPE vs BCAL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Diversified | Banks - Regional | Banks - Regional |
| Market Cap | $90M | $949M | $896.00B | $1.69B | $636M |
| Revenue (TTM) | $59M | $444M | $280.33B | $968M | $233M |
| Net Income (TTM) | $7M | $76M | $57.05B | $59M | $63M |
| Gross Margin | 55.8% | 57.4% | 60.0% | 48.6% | 79.4% |
| Operating Margin | 15.2% | 24.3% | 25.9% | 8.3% | 37.8% |
| Forward P/E | 13.3x | 10.0x | 14.4x | 12.3x | 11.8x |
| Total Debt | $6M | $280M | $942.38B | $396M | $72M |
| Cash & Equiv. | $66M | $213M | $343.34B | $560M | $52M |
SSBI vs HAFC vs JPM vs HOPE vs BCAL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Summit State Bank (SSBI) | 100 | 165.0 | +65.0% |
| Hanmi Financial Cor… (HAFC) | 100 | 327.0 | +227.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| Hope Bancorp, Inc. (HOPE) | 100 | 143.1 | +43.1% |
| Southern California… (BCAL) | 100 | 204.9 | +104.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SSBI vs HAFC vs JPM vs HOPE vs BCAL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SSBI lags the leaders in this set but could rank higher in a more targeted comparison.
HAFC carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 1 yrs, beta 0.82, yield 3.4%
- Beta 0.82, yield 3.4%, current ratio 49.21x
- Lower P/E (10.0x vs 14.4x), PEG 0.79 vs 0.81
- Efficiency ratio 0.3% vs BCAL's 0.4% (lower = leaner)
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs BCAL's 142.1%
HOPE ranks third and is worth considering specifically for dividends.
- 4.2% yield, vs JPM's 1.9%, (1 stock pays no dividend)
BCAL is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 26.2%, EPS growth 7.8%
- Lower volatility, beta 0.69, Low D/E 12.4%, current ratio 0.24x
- PEG 0.38 vs JPM's 0.81
- NIM 4.2% vs JPM's 2.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% NII/revenue growth vs SSBI's -5.2% | |
| Value | Lower P/E (10.0x vs 14.4x), PEG 0.79 vs 0.81 | |
| Quality / Margins | Efficiency ratio 0.3% vs BCAL's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.69 vs HOPE's 0.97, lower leverage | |
| Dividends | 4.2% yield, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +39.4% vs JPM's +21.8% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs BCAL's 0.4% |
SSBI vs HAFC vs JPM vs HOPE vs BCAL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
SSBI vs HAFC vs JPM vs HOPE vs BCAL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BCAL leads in 2 of 6 categories
JPM leads 1 • SSBI leads 0 • HAFC leads 0 • HOPE leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCAL leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4764.1x SSBI's $59M. BCAL is the more profitable business, keeping 27.1% of every revenue dollar as net income compared to HOPE's 6.0%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $59M | $444M | $280.3B | $968M | $233M |
| EBITDAEarnings before interest/tax | $9M | $110M | $81.4B | $84M | $92M |
| Net IncomeAfter-tax profit | $7M | $76M | $57.0B | $59M | $63M |
| Free Cash FlowCash after capex | $7M | $204M | $100.9B | $147M | $57M |
| Gross MarginGross profit ÷ Revenue | +55.8% | +57.4% | +60.0% | +48.6% | +79.4% |
| Operating MarginEBIT ÷ Revenue | +15.2% | +24.3% | +25.9% | +8.3% | +37.8% |
| Net MarginNet income ÷ Revenue | +11.5% | +17.1% | +20.4% | +6.0% | +27.1% |
| FCF MarginFCF ÷ Revenue | +11.1% | +45.8% | +36.0% | +15.2% | +24.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +115.1% | +20.7% | +16.0% | +35.0% | -2.0% |
Valuation Metrics
Evenly matched — SSBI and HAFC and BCAL each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 10.2x trailing earnings, BCAL trades at a 64% valuation discount to HOPE's 28.7x P/E. Adjusting for growth (PEG ratio), BCAL offers better value at 0.32x vs HAFC's 1.00x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $90M | $949M | $896.0B | $1.7B | $636M |
| Enterprise ValueMkt cap + debt − cash | $30M | $1.0B | $1.50T | $1.5B | $655M |
| Trailing P/EPrice ÷ TTM EPS | 13.32x | 12.65x | 16.00x | 28.67x | 10.24x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.05x | 14.40x | 12.33x | 11.84x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.00x | 0.90x | — | 0.32x |
| EV / EBITDAEnterprise value multiple | 3.37x | 8.95x | 18.36x | 18.21x | 7.45x |
| Price / SalesMarket cap ÷ Revenue | 1.53x | 2.13x | 3.20x | 1.74x | 2.73x |
| Price / BookPrice ÷ Book value/share | 0.89x | 1.20x | 2.47x | 0.74x | 1.12x |
| Price / FCFMarket cap ÷ FCF | 13.71x | 4.66x | 8.88x | 11.14x | 11.16x |
Profitability & Efficiency
BCAL leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $3 for HOPE. SSBI carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), HAFC scores 9/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.9% | +9.8% | +15.9% | +2.6% | +11.4% |
| ROA (TTM)Return on assets | +0.7% | +1.0% | +1.3% | +0.3% | +1.6% |
| ROICReturn on invested capital | +6.6% | +7.4% | +4.5% | +2.3% | +10.6% |
| ROCEReturn on capital employed | +1.6% | +2.5% | +8.9% | +0.9% | +5.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 9 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.06x | 0.35x | 2.60x | 0.17x | 0.12x |
| Net DebtTotal debt minus cash | -$60M | $68M | $599.0B | -$164M | $20M |
| Cash & Equiv.Liquid assets | $66M | $213M | $343.3B | $560M | $52M |
| Total DebtShort + long-term debt | $6M | $280M | $942.4B | $396M | $72M |
| Interest CoverageEBIT ÷ Interest expense | 0.38x | 0.62x | 0.74x | 0.17x | 1.55x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $10,696 for HOPE. Over the past 12 months, HAFC leads with a +39.4% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs SSBI's -3.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.9% | +20.3% | -0.5% | +22.7% | +7.1% |
| 1-Year ReturnPast 12 months | +35.7% | +39.4% | +21.8% | +31.7% | +34.3% |
| 3-Year ReturnCumulative with dividends | -9.8% | +116.0% | +138.2% | +66.1% | +45.4% |
| 5-Year ReturnCumulative with dividends | +10.5% | +80.5% | +118.2% | +7.0% | +42.6% |
| 10-Year ReturnCumulative with dividends | +73.1% | +73.3% | +465.8% | +19.5% | +142.1% |
| CAGR (3Y)Annualised 3-year return | -3.4% | +29.3% | +33.6% | +18.4% | +13.3% |
Risk & Volatility
Evenly matched — SSBI and HOPE each lead in 1 of 2 comparable metrics.
Risk & Volatility
SSBI is the less volatile stock with a -0.03 beta — it tends to amplify market swings less than HOPE's 0.97 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOPE currently trades 100.0% from its 52-week high vs JPM's 95.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.03x | 0.82x | 0.94x | 0.97x | 0.69x |
| 52-Week HighHighest price in past year | $14.00 | $31.87 | $337.25 | $13.19 | $20.47 |
| 52-Week LowLowest price in past year | $9.40 | $22.00 | $262.71 | $9.44 | $14.07 |
| % of 52W HighCurrent price vs 52-week peak | +96.1% | +99.6% | +95.1% | +100.0% | +96.6% |
| RSI (14)Momentum oscillator 0–100 | 46.6 | 62.5 | 59.1 | 64.6 | 65.1 |
| Avg Volume (50D)Average daily shares traded | 4K | 203K | 7.0M | 803K | 166K |
Analyst Outlook
Evenly matched — JPM and HOPE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HAFC as "Hold", JPM as "Buy", HOPE as "Hold", BCAL as "Buy". Consensus price targets imply 11.3% upside for BCAL (target: $22) vs 5.5% for HAFC (target: $34). For income investors, HOPE offers the higher dividend yield at 4.16% vs BCAL's 0.50%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $33.50 | $339.75 | $14.50 | $22.00 |
| # AnalystsCovering analysts | — | 11 | 61 | 6 | 3 |
| Dividend YieldAnnual dividend ÷ price | — | +3.4% | +1.9% | +4.2% | +0.5% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 15 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $1.09 | $5.95 | $0.55 | $0.10 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.0% | +3.9% | 0.0% | +0.9% |
BCAL leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JPM leads in 1 (Total Returns). 3 tied.
SSBI vs HAFC vs JPM vs HOPE vs BCAL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SSBI or HAFC or JPM or HOPE or BCAL a better buy right now?
For growth investors, Southern California Bancorp (BCAL) is the stronger pick with 26.
2% revenue growth year-over-year, versus -5. 2% for Summit State Bank (SSBI). Southern California Bancorp (BCAL) offers the better valuation at 10. 2x trailing P/E (11. 8x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SSBI or HAFC or JPM or HOPE or BCAL?
On trailing P/E, Southern California Bancorp (BCAL) is the cheapest at 10.
2x versus Hope Bancorp, Inc. at 28. 7x. On forward P/E, Hanmi Financial Corporation is actually cheaper at 10. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Southern California Bancorp wins at 0. 38x versus JPMorgan Chase & Co. 's 0. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SSBI or HAFC or JPM or HOPE or BCAL?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +7. 0% for Hope Bancorp, Inc. (HOPE). Over 10 years, the gap is even starker: JPM returned +465. 8% versus HOPE's +19. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SSBI or HAFC or JPM or HOPE or BCAL?
By beta (market sensitivity over 5 years), Summit State Bank (SSBI) is the lower-risk stock at -0.
03β versus Hope Bancorp, Inc. 's 0. 97β — meaning HOPE is approximately -3258% more volatile than SSBI relative to the S&P 500. On balance sheet safety, Summit State Bank (SSBI) carries a lower debt/equity ratio of 6% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — SSBI or HAFC or JPM or HOPE or BCAL?
By revenue growth (latest reported year), Southern California Bancorp (BCAL) is pulling ahead at 26.
2% versus -5. 2% for Summit State Bank (SSBI). On earnings-per-share growth, the picture is similar: Southern California Bancorp grew EPS 777. 3% year-over-year, compared to -43. 9% for Hope Bancorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SSBI or HAFC or JPM or HOPE or BCAL?
Southern California Bancorp (BCAL) is the more profitable company, earning 27.
1% net margin versus 6. 0% for Hope Bancorp, Inc. — meaning it keeps 27. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCAL leads at 37. 8% versus 8. 3% for HOPE. At the gross margin level — before operating expenses — BCAL leads at 79. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SSBI or HAFC or JPM or HOPE or BCAL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Southern California Bancorp (BCAL) is the more undervalued stock at a PEG of 0. 38x versus JPMorgan Chase & Co. 's 0. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Hanmi Financial Corporation (HAFC) trades at 10. 0x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 4. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BCAL: 11. 3% to $22. 00.
08Which pays a better dividend — SSBI or HAFC or JPM or HOPE or BCAL?
In this comparison, HOPE (4.
2% yield), HAFC (3. 4% yield), JPM (1. 9% yield), BCAL (0. 5% yield) pay a dividend. SSBI does not pay a meaningful dividend and should not be held primarily for income.
09Is SSBI or HAFC or JPM or HOPE or BCAL better for a retirement portfolio?
For long-horizon retirement investors, Summit State Bank (SSBI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
03)). Both have compounded well over 10 years (SSBI: +73. 1%, HOPE: +19. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SSBI and HAFC and JPM and HOPE and BCAL?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SSBI is a small-cap deep-value stock; HAFC is a small-cap deep-value stock; JPM is a large-cap deep-value stock; HOPE is a small-cap income-oriented stock; BCAL is a small-cap high-growth stock. HAFC, JPM, HOPE, BCAL pay a dividend while SSBI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.